NCT06902402

Brief Summary

The goal of this clinical trial is to demonstrate safety and efficacy of Supportan® Drink

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
15mo left

Started Apr 2025

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Apr 2025Dec 2027

First Submitted

Initial submission to the registry

March 12, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 30, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

April 8, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

2.7 years

First QC Date

March 12, 2025

Last Update Submit

September 30, 2026

Conditions

Malnutrition (Calorie)Cancer

Outcome Measures

Primary Outcomes (1)

  • Change in body weight from Baseline to end of treatment at Week 4 (Week 4 -Baseline)

    4 weeks

Study Arms (1)

Supportan® Drink

EXPERIMENTAL
Dietary Supplement: Supportan® Drink

Interventions

Supportan® DrinkDIETARY_SUPPLEMENT

flavour

Supportan® Drink

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Patients receiving chemotherapy and/or radiotherapy, or immunotherapy, or targeted therapy;

You may not qualify if:

  • \. Patient with documented diagnosis of liver, kidney or heart disease in the hospital's electronic medical record (EMR); severity of disease evaluated by Investigator as not being suitable to participate in this study;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keelung Chang Gung Memorial Hospital-Lover's lake branch

Keelung, Taiwan, 204201, Taiwan

RECRUITING

MeSH Terms

Conditions

NeoplasmsMalnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 30, 2025

Study Start

April 8, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

October 1, 2026

Record last verified: 2026-09

Locations

TW(1)